TCBIO

Value 202020212022202320242025 TTM Total revenue 796.34 M937.07 M1.16 B1 B865.35 M1.2 B 1.2 B Gross profit 538.34 M907.07 M1.09 B931.54 M798.35 M1.15 B 1.15 B Operating expenses 173.91 M157.63 M-27.06 M211.48 M35.17 M209.16 M 236.96 M Selling/general/admin expenses 213.75 M159.58 M221.72 M210.53 M214.48 M214.03 M 242.65 M Research & development —————— — Operating income 364.43 M749.44 M1.12 B720.07 M763.17 M936.62 M 908.82 M Non-Operating Income, Total 4.58 M3.49 M513.52 M4.06 M174 M1.89 M 1.89 M Interest expense, net of interest capitalized 188.09 M107.75 M268.48 M715.8 M878.26 M757.59 M 769.75 M Non-Operating Income, excl. Interest Expenses -183.51 M-104.26 M245.04 M-711.74 M-704.27 M-755.71 M -767.86 M Unusual income/expense —————— — Pretax income 91.95 M338.06 M431.75 M246.59 M107.06 M432.71 M 432.71 M Equity in earnings —————— — Taxes 25.66 M84.12 M99.28 M57.45 M29.55 M102.47 M 102.47 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 66.29 M253.94 M332.48 M189.14 M77.51 M330.24 M 330.24 M Discontinued operations —————— — Net income 66.29 M253.94 M332.48 M189.14 M77.51 M330.24 M 330.24 M Dilution adjustment 000000 0 Preferred dividends 9.75 M18.72 M17.25 M17.25 M17.25 M17.25 M 17.25 M Diluted net income available to common stockholders 56.54 M235.22 M315.23 M171.89 M60.26 M312.99 M 312.99 M Basic earnings per share (Basic EPS) 1.124.656.253.581.296.86 6.86 Diluted earnings per share (Diluted EPS) 1.124.66.183.541.286.79 6.77 Average basic shares outstanding 50.43 M50.58 M50.46 M48.05 M46.56 M45.64 M 183.59 M Diluted shares outstanding 50.58 M51.14 M51.05 M48.61 M46.99 M46.13 M 185.5 M EBITDA 439.36 M842.84 M1.17 B760.54 M817.4 M988.79 M 960.99 M EBIT 364.43 M749.44 M1.12 B720.07 M763.17 M936.62 M 908.82 M Cost of revenue 258 M30 M66 M72 M67 M55 M 55 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) 74.92 M93.41 M45.28 M40.47 M54.23 M52.17 M 52.17 M